nature.com search

Loading Filters

Showing 1–29 of 29 results

Loading Filters

25 March 2016 | Open
Evolution in the treatment of multiple myeloma and impact on dialysis independence: data from a French cohort from 1999 to 2014
- M Laforet
- , N Jourde-Chiche
- , F Haddad
- , M Sallee
- , A M Stoppa
- , P Brunet
- , B Dussol
- , S Burtey
- & B Gondouin
Blood Cancer Journal 6 , e409–e409

Rights & permissionsfor article Evolution in the treatment of multiple myeloma and impact on dialysis independence: data from a French cohort from 1999 to 2014 . Opens in a new window.
Amendments and Corrections | 5 March 2014
Erratum: Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
- B Hebraud
- , X Leleu
- , V Lauwers-Cances
- , M Roussel
- , D Caillot
- , G Marit
- , L Karlin
- , C Hulin
- , C Gentil
- , F Guilhot
- , L Garderet
- , T Lamy
- , S Brechignac
- , B Pegourie
- , J Jaubert
- , M Dib
- , A-M Stoppa
- , C Sebban
- , C Fohrer
- , J Fontan
- , C Fruchart
- , M Macro
- , F Orsini-Piocelle
- , G Lepeu
- , C Sohn
- , J Corre
- , T Facon
- , P Moreau
- , M Attal
- & H Avet-Loiseau
Leukemia 28 , 726–726

Rights & permissionsfor article Erratum: Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients . Opens in a new window.
2 November 2015
Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicity
- S Garciaz
- , D Coso
- , J-M Schiano de Collela
- , F Broussais
- , A-M Stoppa
- , T Aurran
- , C Chabannon
- , A Helvig
- , L Xerri
- , D Blaise
- & R Bouabdallah
Bone Marrow Transplantation 51 , 319–321

Rights & permissionsfor article Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicity . Opens in a new window.
2 June 2014
Automated washing of autologous hematopoietic stem cell grafts after thawing does not impair engraftment
- B Calmels
- , A Drezet
- , C Huynh
- , A Autret
- , A-M Stoppa
- , R Bouabdallah
- , D Coso
- , C Malenfant
- , C Lemarié
- & C Chabannon
Bone Marrow Transplantation 49 , 1127–1128

Rights & permissionsfor article Automated washing of autologous hematopoietic stem cell grafts after thawing does not impair engraftment . Opens in a new window.
29 April 2010
Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005–01 trial
- P Moreau
- , C Hulin
- , G Marit
- , D Caillot
- , T Facon
- , P Lenain
- , C Berthou
- , B Pégourié
- , A M Stoppa
- , P Casassus
- , M Michallet
- , L Benboubker
- , H Maisonneuve
- , C Doyen
- , S Leyvraz
- , C Mathiot
- , H Avet-Loiseau
- , M Attal
- & J L Harousseau
Leukemia 24 , 1233–1235

Rights & permissionsfor article Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005–01 trial . Opens in a new window.
Correspondence | 23 July 1999
Transplantation of allogeneic CD34⁺ blood cells in leukemia or lymphoma patients at high risk of GVHD
- F Viret
- , C Chabannon
- , T Aurran-Schleinitz
- , D Reviron
- , A-M Stoppa
- , C Faucher
- , P Ladaique
- , J-A Gastaut
- , D Maraninchi
- & D Blaise
Bone Marrow Transplantation 24 , 225–227

Rights & permissionsfor article Transplantation of allogeneic CD34+ blood cells in leukemia or lymphoma patients at high risk of GVHD . Opens in a new window.
13 February 2006
Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission
- H de Lavallade
- , C Faucher
- , S Fürst
- , J El-Cheikh
- , N Vey
- , D Coso
- , R Bouabdallah
- , A-M Stoppa
- , J-A Gastaut
- , D Blaise
- & M Mohty
Bone Marrow Transplantation 37 , 709–710

Rights & permissionsfor article Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission . Opens in a new window.
26 June 2008
Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison
- M Mohty
- , H de Lavallade
- , J El-Cheikh
- , P Ladaique
- , C Faucher
- , S Fürst
- , N Vey
- , D Coso
- , A-M Stoppa
- , J-A Gastaut
- , C Chabannon
- & D Blaise
Leukemia 23 , 194–196

Rights & permissionsfor article Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison . Opens in a new window.
Research | 24 November 2005
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
- S de Botton
- , M A Sanz
- , S Chevret
- , H Dombret
- , G Martin
- , X Thomas
- , J D Mediavilla
- , C Recher
- , L Ades
- , B Quesnel
- , P Brault
- , M Fey
- , H Wandt
- , D Machover
- , A Guerci
- , F Maloisel
- , A M Stoppa
- , C Rayon
- , J M Ribera
- , C Chomienne
- , L Degos
- & P Fenaux
Leukemia 20 , 35–41

Rights & permissionsfor article Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy . Opens in a new window.
Correspondence | 8 April 2003
Cost–effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation
- C Chabannon
- , A-G Le Corroller
- , F Viret
- , C Eillen
- , C Faucher
- , J-P Moatti
- , P Viens
- , N Vey
- , A-C Braud
- , G Novakovitch
- , P Ladaique
- , A-M Stoppa
- , J Camerlo
- , D Genre
- , D Maraninchi
- & D Blaise
Leukemia 17 , 811–813

Rights & permissionsfor article Cost–effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation . Opens in a new window.
Research | 4 April 2017 | Open
Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial
- N J Bahlis
- , A Corso
- , L-O Mugge
- , Z-X Shen
- , P Desjardins
- , A-M Stoppa
- , O Decaux
- , T de Revel
- , M Granell
- , G Marit
- , H Nahi
- , H Demuynck
- , S-Y Huang
- , S Basu
- , T H Guthrie
- , A Ervin-Haynes
- , J Marek
- , G Chen
- & T Facon
Leukemia 31 , 2435–2442

Rights & permissionsfor article Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial . Opens in a new window.
Research | 10 November 2014
Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years
- H W Auner
- , R Szydlo
- , J Hoek
- , H Goldschmidt
- , A M Stoppa
- , G J Morgan
- , P Moreau
- , M Attal
- , G Marit
- , N Russell
- , M Brune
- , G Cook
- , P Sonneveld
- , S Schönland
- , L Garderet
- & N Kröger
Bone Marrow Transplantation 50 , 209–215

Rights & permissionsfor article Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years . Opens in a new window.
Research | 29 July 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
- B Hebraud
- , X Leleu
- , V Lauwers-Cances
- , M Roussel
- , D Caillot
- , G Marit
- , L Karlin
- , C Hulin
- , C Gentil
- , F Guilhot
- , L Garderet
- , T Lamy
- , S Brechignac
- , B Pegourie
- , J Jaubert
- , M Dib
- , A-M Stoppa
- , C Sebban
- , C Fohrer
- , J Fontan
- , C Fruchart
- , M Macro
- , F Orsini-Piocelle
- , G Lepeu
- , C Sohn
- , J Corre
- , T Facon
- , P Moreau
- , M Attal
- & H Avet-Loiseau
Leukemia 28 , 675–679

Rights & permissionsfor article Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients . Opens in a new window.
5 April 2013
Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma
- X Leleu
- , G Fouquet
- , B Hebraud
- , M Roussel
- , D Caillot
- , M L Chrétien
- , B Arnulf
- , R Szalat
- , L Garderet
- , L Benajiba
- , B Pegourie
- , C Regny
- , B Royer
- , A Caulier
- , A M Stoppa
- , S Garciaz
- , C Touzeau
- , C Chaleteix
- , J P Fermand
- , H A Loiseau
- , T Facon
- , M Attal
- & P Moreau
Leukemia 27 , 2242–2244

Rights & permissionsfor article Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma . Opens in a new window.
Research | 2 August 2004
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
- M Mohty
- , H de Lavallade
- , C Faucher
- , K Bilger
- , N Vey
- , A-M Stoppa
- , G Gravis
- , D Coso
- , P Viens
- , J-A Gastaut
- & D Blaise
Bone Marrow Transplantation 34 , 527–530

Rights & permissionsfor article Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation . Opens in a new window.
12 June 1999
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high–intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin’s lymphoma: an oligocentric report on 42 patients
- R Bouabdallah
- , A-M Stoppa
- , J-F Rossi
- , G Lepeu
- , D Coso
- , L Xerri
- , P Ladaique
- , C Chabannon
- , D Blaise
- , V-J Bardou
- , C Alzieu
- , J-A Gastaut
- & D Maraninchi
Leukemia 13 , 950–956

Rights & permissionsfor article Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high–intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin’s lymphoma: an oligocentric report on 42 patients . Opens in a new window.
Research | 25 February 2008
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma
- H de Lavallade
- , J El-Cheikh
- , C Faucher
- , S Fürst
- , A-M Stoppa
- , D Coso
- , R Bouabdallah
- , C Chabannon
- , J-A Gastaut
- , D Blaise
- & M Mohty
Bone Marrow Transplantation 41 , 953–960

Rights & permissionsfor article Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma . Opens in a new window.
Research | 29 January 2007
High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation
- J El-Cheikh
- , C Faucher
- , S Fürst
- , S Duran
- , P Berger
- , N Vey
- , A-M Stoppa
- , R Bouabdallah
- , J-A Gastaut
- , P Viens
- , D Blaise
- & M Mohty
Bone Marrow Transplantation 39 , 301–306

Rights & permissionsfor article High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation . Opens in a new window.
Research | 12 June 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma
- D Coso
- , C Sebban
- , O Boulat
- , P Biron
- , J Rey
- , T Aurran
- , C Chabannon
- , L Xerri
- , B Chetaille
- , B Esterni
- , V Ivanov
- , A M Stoppa
- , J M Schiano de Collela
- , J A Gastaut
- , D Maraninchi
- & R Bouabdallah
Bone Marrow Transplantation 38 , 217–222

Rights & permissionsfor article A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma . Opens in a new window.
1 July 1998
Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation
- L Xerri
- , R Bouabdallah
- , E Devilard
- , J Hassoun
- , A-M Stoppa
- & F Birg
British Journal of Cancer 78 , 225–232

Rights & permissionsfor article Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation . Opens in a new window.
4 August 2000
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
- P Fenaux
- , S Chevret
- , A Guerci
- , N Fegueux
- , H Dombret
- , X Thomas
- , M Sanz
- , H Link
- , F Maloisel
- , C Gardin
- , D Bordessoule
- , A-M Stoppa
- , A Sadoun
- , P Muus
- , H Wandt
- , P Mineur
- , JA Whittaker
- , M Fey
- , M-T Daniel
- , S Castaigne
- & L Degos
Leukemia 14 , 1371–1377

Rights & permissionsfor article Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia . Opens in a new window.
Research | 10 May 2004
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation
- M Mohty
- , J M Boiron
- , G Damaj
- , A S Michallet
- , J O Bay
- , C Faucher
- , V Perreau
- , K Bilger
- , D Coso
- , A M Stoppa
- , R Tabrizi
- , J A Gastaut
- , M Michallet
- , D Maraninchi
- & D Blaise
Bone Marrow Transplantation 34 , 77–84

Rights & permissionsfor article Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation . Opens in a new window.
21 April 2005
The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison
- M Mohty
- , H de Lavallade
- , P Ladaique
- , C Faucher
- , N Vey
- , D Coso
- , A-M Stoppa
- , J-A Gastaut
- & D Blaise
Leukemia 19 , 916–920

Rights & permissionsfor article The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison . Opens in a new window.
Research | 4 July 2011
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs
- C Faucher
- , A G Le Corroller Soriano
- , B Esterni
- , N Vey
- , A M Stoppa
- , C Chabannon
- , M Mohty
- , M Michallet
- , J O Bay
- , D Genre
- , D Maraninchi
- , P Viens
- , J P Moatti
- & D Blaise
Bone Marrow Transplantation 47 , 549–555

Rights & permissionsfor article Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs . Opens in a new window.
25 November 2004
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience
- L Ades
- , S Chevret
- , S De Botton
- , X Thomas
- , H Dombret
- , B Beve
- , M Sanz
- , A Guerci
- , J S Miguel
- , J dela Serna
- , C Garo
- , A M Stoppa
- , O Reman
- , A Stamatoulas
- , M Fey
- , J Y Cahn
- , J J Sotto
- , J H Bourhis
- , A Parry
- , C Chomienne
- , L Degos
- & P Fenaux
Leukemia 19 , 230–233

Rights & permissionsfor article Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience . Opens in a new window.
Research | 4 October 2010
Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT
- L Castagna
- , S Fürst
- , N Marchetti
- , J El Cheikh
- , C Faucher
- , M Mohty
- , R Bouabdallah
- , N Vey
- , A M Stoppa
- , B Esterni
- & D Blaise
Bone Marrow Transplantation 46 , 1000–1005

Rights & permissionsfor article Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT . Opens in a new window.
12 May 2005
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group
- C Callens
- , S Chevret
- , J-M Cayuela
- , B Cassinat
- , E Raffoux
- , S de Botton
- , X Thomas
- , A Guerci
- , N Fegueux
- , A Pigneux
- , A-M Stoppa
- , T Lamy
- , F Rigal-Huguet
- , A Vekhoff
- , S Meyer-Monard
- , A Ferrand
- , M Sanz
- , C Chomienne
- , P Fenaux
- & H Dombret
Leukemia 19 , 1153–1160

Rights & permissionsfor article Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group . Opens in a new window.
Research | 9 August 2012
Minor clone provides a reservoir for relapse in multiple myeloma
- F Magrangeas
- , H Avet-Loiseau
- , W Gouraud
- , L Lodé
- , O Decaux
- , P Godmer
- , L Garderet
- , L Voillat
- , T Facon
- , A M Stoppa
- , G Marit
- , C Hulin
- , P Casassus
- , M Tiab
- , E Voog
- , E Randriamalala
- , K C Anderson
- , P Moreau
- , N C Munshi
- & S Minvielle
Leukemia 27 , 473–481

Rights & permissionsfor article Minor clone provides a reservoir for relapse in multiple myeloma . Opens in a new window.
14 August 2003
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen
- M Mohty
- , W Jacot
- , C Faucher
- , J O Bay
- , C Zandotti
- , L Collet
- , B Choufi
- , K Bilger
- , O Tournilhac
- , N Vey
- , A M Stoppa
- , D Coso
- , J A Gastaut
- , P Viens
- , D Maraninchi
- , D Olive
- & D Blaise
Leukemia 17 , 2168–2177

Rights & permissionsfor article Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen . Opens in a new window.

Refine your results by…

Filters

Filter By:

Evolution in the treatment of multiple myeloma and impact on dialysis independence: data from a French cohort from 1999 to 2014

Erratum: Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicity

Automated washing of autologous hematopoietic stem cell grafts after thawing does not impair engraftment

Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005–01 trial

Transplantation of allogeneic CD34⁺ blood cells in leukemia or lymphoma patients at high risk of GVHD

Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission

Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Cost–effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial

Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma

Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation

Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high–intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin’s lymphoma: an oligocentric report on 42 patients

Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma

High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation

A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma

Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia

Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation

The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison

Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs

Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience

Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group

Minor clone provides a reservoir for relapse in multiple myeloma

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters